Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 264

1.

Iron deficiency in patients with renal failure.

Nissenson AR, Strobos J.

Kidney Int Suppl. 1999 Mar;69:S18-21. Review.

PMID:
10084282
2.

Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.

Ahluwalia N, Skikne BS, Savin V, Chonko A.

Am J Kidney Dis. 1997 Oct;30(4):532-41.

PMID:
9328369
3.
4.

Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.

Tarng DC, Huang TP, Chen TW, Yang WC.

Kidney Int Suppl. 1999 Mar;69:S107-18. Review.

PMID:
10084294
5.

Current concepts of anemia management in chronic renal failure: impact of NKF-DOQI.

Eschbach JW.

Semin Nephrol. 2000 Jul;20(4):320-9. Review.

PMID:
10928333
6.
7.

[Anemia in peritoneal dialysis patients].

Lausević M, Nesić V, Jovanović N, Stojimirović B.

Srp Arh Celok Lek. 2006 Mar-Apr;134(3-4):133-7. Serbian.

8.

Nononcologic use of human recombinant erythropoietin therapy in hospitalized patients.

Fischer MA, Morris CA, Winkelmayer WC, Avorn J.

Arch Intern Med. 2007 Apr 23;167(8):840-6.

PMID:
17452549
9.

Is it time for a paradigm shift? Is erythropoietin deficiency still the main cause of renal anaemia?

Eschbach JW, Varma A, Stivelman JC.

Nephrol Dial Transplant. 2002;17 Suppl 5:2-7.

10.

Iron replacement in rHuEPO-treated dialysis patients: DOQI and beyond.

Mittman N.

Am J Kidney Dis. 1999 Jul;34(1):173-6. No abstract available.

PMID:
10401035
11.

Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients.

Dittrich E, Schillinger M, Sunder-Plassmann G, Hörl WH, Vychytil A.

Perit Dial Int. 2002 Jan-Feb;22(1):60-6.

12.
13.

2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.

Gejyo F, Saito A, Akizawa T, Akiba T, Sakai T, Suzuki M, Nishi S, Tsubakihara Y, Hirakata H, Bessho M; Japanese Society for Dialysis Therapy.

Ther Apher Dial. 2004 Dec;8(6):443-59.

PMID:
15663544
14.

Erythropoietin and renal transplantation.

Muirhead N.

Kidney Int Suppl. 1999 Mar;69:S86-92. Review.

PMID:
10084292
15.
16.

The role of iron in erythropoiesis in the absence and presence of erythropoietin therapy.

Goodnough LT.

Nephrol Dial Transplant. 2002;17 Suppl 5:14-8. Review.

17.
18.

Iron management in end-stage renal disease.

Fishbane S, Maesaka JK.

Am J Kidney Dis. 1997 Mar;29(3):319-33. Review.

PMID:
9041207
19.

Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.

Drüeke TB, Bárány P, Cazzola M, Eschbach JW, Grützmacher P, Kaltwasser JP, Macdougall IC, Pippard MJ, Shaldon S, van Wyck D.

Clin Nephrol. 1997 Jul;48(1):1-8. Review.

PMID:
9247771
20.

Iron supplementation in renal anemia.

Fishbane S.

Semin Nephrol. 2006 Jul;26(4):319-24. Review.

PMID:
16949471
Items per page

Supplemental Content

Write to the Help Desk